Dr. Jonathan Kay discusses a new study asking whether acute-phase reactant profiles correlate with clinical disease activity in patients with rheumatoid arthritis.
Dr. Jonathan Kay discusses a new study asking whether acute-phase reactant profiles correlate with clinical disease activity in patients with rheumatoid arthritis.